CNS Neuroscience & Therapeutics,
Год журнала:
2024,
Номер
30(12)
Опубликована: Дек. 1, 2024
ABSTRACT
Background
Esketamine
(ESK),
a
noncompetitive
antagonist
of
N‐methyl‐D‐aspartate
(NMDA)
receptors,
modulates
neurotransmitter
signaling
in
the
central
nervous
system.
However,
specific
mechanisms
and
therapeutic
potential
ESK
for
intracerebral
hemorrhage
(ICH)
remain
unclear.
This
study
aimed
to
investigate
whether
promotes
nerve
repair
improves
neurological
outcomes
an
experimental
model
ICH.
Methods
ICH
was
induced
mice
via
collagenase
injection
into
striatum.
Body
weight,
impairment,
behavioral
changes
were
assessed.
administration
significantly
improved
several
indicators
Comprehensive
RNA
transcriptome
sequencing
network
pharmacology
analyses
identified
neurotrophin‐3
(NTF3)
PI3K/AKT
pathway
as
targets
treatment.
Western
blotting
immunofluorescence
detected
protein
expression
levels
cellular
localization
NTF3.
Results
After
28
days
adeno‐associated
virus
infection
mouse
striatum,
treatment
enhanced
neuroprotection,
indicating
crucial
role
NTF3
ESK‐mediated
neuroprotection
mice.
Inhibition
using
PI3K‐specific
inhibitor
LY294002
attenuated
effects
ESK,
suggesting
that
this
is
involved
neurorepair
Conclusions
functional
demonstrated
neuroprotective
animal
models
NTF3/PI3K/AKT
activation
by
indicates
its
BMC Anesthesiology,
Год журнала:
2024,
Номер
24(1)
Опубликована: Фев. 15, 2024
Postoperative
pain
is
common
in
pediatric
urological
surgery.
The
study
assess
the
impact
of
perioperative
intravenous
infusion
low-dose
esketamine
on
postoperative
Journal of Pain Research,
Год журнала:
2025,
Номер
Volume 18, С. 229 - 241
Опубликована: Янв. 1, 2025
Postoperative
sore
throat
(POST)
is
a
significant
adverse
effect
after
endotracheal
intubation,
especially
with
double-lumen
tubes
(DLTs).
Ultrasound-guided
internal
branch
of
the
superior
laryngeal
nerve
block
(US-guided
iSLNB)
presents
potential
intervention
for
POST.
In
this
first
randomized
controlled
trial
to
date,
we
aimed
investigate
effects
US-guided
iSLNB,
or
without
perineural
dexmedetomidine,
on
incidence
and
severity
POST
following
DLTs.
A
total
159
patients
were
randomly
assigned
three
groups:
control,
bilateral
iSLNB
(2
mL
0.20%
ropivacaine
+
1
saline
each
side),
combined
dexmedetomidine
group
0.5
μg·kg-1
side).
The
POST,
hemodynamic
fluctuations
during
intubation
extubation,
cough
agitation
perioperative
complications
assessed.
primary
outcome
was
at
6
h
surgery.
Compared
control
group,
preoperative
significantly
reduced
surgery,
mitigated
attenuated
responses,
including
heart
rate,
mean
arterial
pressure,
rate-pressure
product
min
extubation
(all
P
<
0.01).
alone,
combination
1,
6,
12
h,
as
well
coughing
However,
it
demonstrated
little
hemodynamics
>
0.05).
No
observed
in
groups
Preoperative
effectively
incidence,
severity,
duration
extubation.
additional
benefits
observed.
Chinese
Clinical
Trial
Registry
(ChiCTR2200061001).
Drug Design Development and Therapy,
Год журнала:
2025,
Номер
Volume 19, С. 1971 - 1981
Опубликована: Март 1, 2025
Recently,
opioid-sparing
(OS)
interventions
have
been
proposed
to
facilitate
rapid
postoperative
recovery
for
patients.
However,
the
advantages
of
OS
anesthesia
strategy
in
laparoscopic
abdominal
major
surgery
are
still
unknown.
157
patients
undergoing
were
randomly
assigned
two
groups:
Remi
(77,
remifentanil)
and
(80,
esketamine
combined
with
dexmedetomidine),
drugs
administered
at
0.2-0.5
mg/kg/h
(remifentanil
or
esketamine)
0.2-0.7μg/kg/h
dexmedetomidine)
syringes,
respectively
The
primary
outcome
was
numeric
rating
scale
(NRS)
pain
score
on
day
(POD)1.
proportion
rescue
analgesia
within
48
h,
extubation
time,
quality
recover
(PQRS),
Pittsburgh
Sleep
Quality
Index
(PSQI)
POD30
also
recorded.
In
postanaesthesia
care
unit
(PACU),
NRS
group
significantly
higher
than
that
(3
[1
3]
vs
1
3],
P
=
0.001;
15.6%
5.0%,
0.028,
respectively),
although
there
no
statistical
differences
POD1,
POD7
between
groups
[2
3
0.648;
2
2]
2],
0.418;
0
1]
1],
0.656,
respectively).
time
longer
dreaminess
(20
[11
34]
31
[21
40],
<
0.01;
42.5%,
0.01),
PSQI
similar
(8.27±3.94
8.37±3.89,
0.870).
this
study,
during
decreases
scores
PACU
reduces
use
analgesia,
though
it
may
prolong
increase
hospitalization.
ChiCTR2200060130.
Frontiers in Medicine,
Год журнала:
2025,
Номер
12
Опубликована: Апрель 2, 2025
Breast
cancer
is
the
most
common
malignant
tumor
among
women
worldwide.
Surgical
intervention
a
critical
component
of
treatment,
yet
associated
stress
and
anxiety
can
significantly
disrupt
postoperative
sleep
quality.
Emerging
evidences
suggest
that
esketamine
may
offer
benefits
in
alleviating
emotional
distress
enhancing
sleep.
The
purpose
this
study
was
to
observe
effects
intraoperative
subanesthetic
dose
on
patients
undergoing
modified
radical
mastectomy.
This
randomized,
double-blind,
controlled
trial
enrolled
145
female
patients,
who
were
randomly
assigned
either
group
(Group
E,
n
=
72)
or
control
C,
73).
Patients
Group
E
received
(0.2
mg/kg
loading
dose,
followed
by
0.1
mg/kg/h
infusion),
while
those
C
saline
mL/kg
mL/kg/h
infusion).
primary
outcome
total
score
Richards-Campbell
Sleep
Questionnaire
(RCSQ)
measured
day
(POD)
1.
Secondary
outcomes
included
recovery
time,
incidence
adverse
events
rescue
analgesia,
Visual
Analogue
Scale
(VAS)
pain
scores,
short-form
McGill's
Pain
(SF-MPQ)
sensory
affective
Pittsburgh
Quality
Index
(PSQI)
scores.
No
significant
differences
observed
RCSQ
scores
POD
1
between
(median
[interquartile
range]:
46
[32-68]
vs.
54
[40-71],
p
>
0.05).
Recovery
time
longer
compared
(8
[5-11]
6
[4-11]
minutes;
0.02).
There
no
remedial
analgesia
within
48
h
postoperatively.
Furthermore,
groups
VAS
SF-MPQ
at
4,
24,
PSQI
30
not
different
(p
For
without
pre-existing
disorders
mastectomy,
impact
quality
but
potentially
contribute
prolonged
time.
registered
Chinese
Clinical
Trial
Registry
July
03,
2022
(https://www.chictr.org.cn;
Registration
number:
ChiCTR2200061818).
Neuropsychiatric Disease and Treatment,
Год журнала:
2025,
Номер
Volume 21, С. 815 - 825
Опубликована: Апрель 1, 2025
Pregnancy
leads
to
vulnerabilities
and
susceptibilities
mental
disorders.
Miscarriage,
as
an
adverse
pregnancy
outcome,
following
curettage
for
treatment,
add
the
risks
of
further
psychiatric
disorders,
including
depression,
anxiety,
insomnia,
etc.,
current
approaches
prevention
are
unsatisfactory.
Ketamine
its
S-enantiomer
esketamine
can
prevent
postpartum
even
treats
depressive
symptoms
after
miscarriage
curettage,
but
their
side
effects
bring
limitations.
Ascorbic
acid
(AA,
Vitamin
C)
modulate
mood
enhance
ketamine's
antidepressant
efficacy
synergistically,
reducing
dosages
potentially.
The
purpose
this
study
is
clarify
beneficial
modification
AA
on
preventing
depression
other
disorders
in
patients
with
painless
well
interaction
between
esketamine.
This
a
2×2
factorial,
double-blinded,
randomized,
controlled
trial
that
will
recruit
women
undergoing
curettage.
A
total
424
participants
be
recruited
randomly
1:1:1:1
allocated
four
groups
(106
each):
Group
A0K0
(normal
saline
normal
saline),
A0K1
esketamine),
A1K0
(AA
A1K1
esketamine).
primary
outcome
incidence
postoperative
day
7,
assessed
Edinburgh
Postnatal
Depression
Scale
(EPDS).
secondary
outcomes
include
EPDS
score,
assessments
sleep,
pain,
events,
perianesthetic
data
patient
satisfaction.
provides
clinical
trial-based
evidence
alone
or
combination/interacting
emerging
rapid-acting
Our
expected
suggest
AA's
potential
application
optimizing
strategies
promoting
post-miscarriage
health,
possible
adjunctive
improvement
(es)ketamine's
usage
antidepressants.
One
major
limitation
single-center
study,
results
might
biased
due
regional
factors.
Indian Journal of Anaesthesia,
Год журнала:
2025,
Номер
69(5), С. 434 - 449
Опубликована: Апрель 16, 2025
Background
and
Aims:
Postoperative
sleep
disturbance
(PSD)
is
a
common
condition
that
may
lead
to
pain,
cognitive
impairment,
depression,
delayed
recovery.
This
review
evaluates
the
efficacy
of
perioperative
intravenous
ketamine
in
alleviating
PSD
offers
evidence-based
recommendations
for
clinical
practice.
Methods:
A
systematic
search
was
performed
PubMed,
Embase,
Cochrane
Library,
Wanfang
Data,
VIP
Information
Resource
System,
China
National
Knowledge
Infrastructure
Biology
Medicine
disc
(SinoMed)
up
6
th
November
2024.
article
included
meta-analysis
randomised
controlled
trials
(RCTs)
along
with
Grading
Recommendations
Assessment,
Development
Evaluation
analysis.
Results:
total
2355
patients
from
21
RCTs
were
analysed.
The
pooled
results
indicated
improved
quality
compared
placebo
on
first
postoperative
day,
as
evidenced
by
reduction
Pittsburgh
Sleep
Quality
Index
scores
[mean
difference
(MD):
−2.69;
95%
confidence
interval
(CI):
−3.95,
−1.42;
P
<
0.0001,
I
2
=
96%].
Ketamine
also
second
day
(MD:
−2.45;
CI:
−3.99,
−0.91;
0.002,
96%)
during
three
days
−2.90;
−4.79,
−1.00;
0.003,
97%).
In
addition,
reduced
Visual
Analogue
Scale
pain
−0.38;
−0.55,
−0.21;
0.00001,
84%).
These
suggest
reduces
PSDs
without
significantly
increasing
adverse
reactions.
However,
given
high
heterogeneity
limited
evidence
this
review,
should
be
interpreted
caution.
Conclusion:
indicates
administering
period
can
enhance
quality.
optimal
dose,
timing
method
administration
remain
undetermined,
emphasising
need
further
research
establish
standardised
guidelines.